Cas:25641-99-0 1,2-bis(dichloromethyl)benzene manufacturer & supplier

Chemical Name:1,2-bis(dichloromethyl)benzene

CAS.NO:25641-99-0

Synonyms:EINECS 247-159-4;α,α,α’,α’-Tetrachloro-o-xylene;MFCD00000831;Benzene,1,2-bis(dichloromethyl);1,2-Bis-dichlormethyl-benzol;o-Xylylene Tetrachloride;1,2-bis-dichloromethyl-benzene

Molecular Formula:C₈H₆Cl₄

Molecular Weight:243.94500

HS Code:2903999090

Physical and Chemical Properties:

Melting point:85°C

Boiling point:274 °C

Density:1.442 g/cm3

Index of Refraction:1.57

PSA:

Exact Mass:241.92200

LogP:4.63900

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:1759

Packing Group:III

Contact us for information like EINECS 247-159-4 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,2-bis-dichloromethyl-benzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,α,α,α’,α’-Tetrachloro-o-xylene Use and application,Benzene,1,2-bis(dichloromethyl) technical grade,usp/ep/jp grade.

Related News: South Korea said on Sunday that it would deny entry to any foreigners who have traveled to Wuhan and surrounding Hubei Province in China in the past 14 days. 1,2-bis(dichloromethyl)benzene manufacturer A new case of coronavirus has been reported in the United Arab Emirates, the country’s fifth, the Ministry of Health and Prevention announced on Saturday. 1,2-bis(dichloromethyl)benzene supplier ��Administrative Measures for the Joint Review, Review and Approval of Raw Materials, Medicinal Auxiliaries and Pharmaceutical Packaging Materials and Pharmaceutical Preparations�� (Consultation Draft) issued by the State Food and Drug Administration in December 2017. Supervision departments no longer accept applications for registration of APIs, pharmaceutical excipients, and packaging materials. 1,2-bis(dichloromethyl)benzene vendor ��Administrative Measures for the Joint Review, Review and Approval of Raw Materials, Medicinal Auxiliaries and Pharmaceutical Packaging Materials and Pharmaceutical Preparations�� (Consultation Draft) issued by the State Food and Drug Administration in December 2017. Supervision departments no longer accept applications for registration of APIs, pharmaceutical excipients, and packaging materials. 1,2-bis(dichloromethyl)benzene factory This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved.